489402-47-3,MFCD23136017
Catalog No.:AA00DA8L

489402-47-3 | ML213

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
95%
in stock  
$6.00   $4.00
- +
5mg
95%
in stock  
$16.00   $11.00
- +
10mg
95%
in stock  
$24.00   $17.00
- +
25mg
95%
in stock  
$39.00   $28.00
- +
50mg
95%
in stock  
$66.00   $47.00
- +
100mg
95%
in stock  
$111.00   $78.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00DA8L
Chemical Name:
ML213
CAS Number:
489402-47-3
Molecular Formula:
C17H23NO
Molecular Weight:
257.3706
MDL Number:
MFCD23136017
SMILES:
O=C(C1CC2CC1CC2)Nc1c(C)cc(cc1C)C
Properties
Computed Properties
 
Complexity:
341  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
19  
Hydrogen Bond Acceptor Count:
1  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
2  
Undefined Atom Stereocenter Count:
3  
XLogP3:
4.2  

Literature

Title: Discovery, Synthesis, and Structure Activity Relationship of a Series of N-Aryl- bicyclo[2.2.1]heptane-2-carboxamides: Characterization of ML213 as a Novel KCNQ2 and KCNQ4 Potassium Channel Opener.

Journal: ACS chemical neuroscience 20111019

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Title: Brueggemann LI, et al. Differential activation of vascular smooth muscle Kv7.4, Kv7.5, and Kv7.4/7.5 channels by ML213 and ICA-069673. Mol Pharmacol. 2014 Sep;86(3):330-41.

Title: Jepps TA, et al. Vasorelaxant effects of novel Kv 7.4 channel enhancers ML213 and NS15370. Br J Pharmacol. 2014 Oct;171(19):4413-24.

Title: Yu H, et al. Discovery, Synthesis, and Structure Activity Relationship of a Series of N-Aryl- bicyclo.2.1heptane-2-carboxamides: Characterization of ML213 as a Novel KCNQ2 and KCNQ4 Potassium Channel Opener. ACS Chem Neurosci. 2011 Oct 19;2(10):572-577.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:489402-47-3 Molecular Formula|489402-47-3 MDL|489402-47-3 SMILES|489402-47-3 ML213
Catalog No.: AA00DA8L
489402-47-3,MFCD23136017
489402-47-3 | ML213
Pack Size: 1mg
Purity: 95%
in stock
$6.00 $4.00
Pack Size: 5mg
Purity: 95%
in stock
$16.00 $11.00
Pack Size: 10mg
Purity: 95%
in stock
$24.00 $17.00
Pack Size: 25mg
Purity: 95%
in stock
$39.00 $28.00
Pack Size: 50mg
Purity: 95%
in stock
$66.00 $47.00
Pack Size: 100mg
Purity: 95%
in stock
$111.00 $78.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00DA8L
Chemical Name: ML213
CAS Number: 489402-47-3
Molecular Formula: C17H23NO
Molecular Weight: 257.3706
MDL Number: MFCD23136017
SMILES: O=C(C1CC2CC1CC2)Nc1c(C)cc(cc1C)C
Properties
Complexity: 341  
Covalently-Bonded Unit Count: 1  
Heavy Atom Count: 19  
Hydrogen Bond Acceptor Count: 1  
Hydrogen Bond Donor Count: 1  
Rotatable Bond Count: 2  
Undefined Atom Stereocenter Count: 3  
XLogP3: 4.2  
Literature fold

Title: Discovery, Synthesis, and Structure Activity Relationship of a Series of N-Aryl- bicyclo[2.2.1]heptane-2-carboxamides: Characterization of ML213 as a Novel KCNQ2 and KCNQ4 Potassium Channel Opener.

Journal: ACS chemical neuroscience20111019

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology20060501

Title: Brueggemann LI, et al. Differential activation of vascular smooth muscle Kv7.4, Kv7.5, and Kv7.4/7.5 channels by ML213 and ICA-069673. Mol Pharmacol. 2014 Sep;86(3):330-41.

Title: Jepps TA, et al. Vasorelaxant effects of novel Kv 7.4 channel enhancers ML213 and NS15370. Br J Pharmacol. 2014 Oct;171(19):4413-24.

Title: Yu H, et al. Discovery, Synthesis, and Structure Activity Relationship of a Series of N-Aryl- bicyclo.2.1heptane-2-carboxamides: Characterization of ML213 as a Novel KCNQ2 and KCNQ4 Potassium Channel Opener. ACS Chem Neurosci. 2011 Oct 19;2(10):572-577.

Building Blocks More >
475102-12-6
475102-12-6
1-Boc-5-chloro-1H-indole-2-boronic acid
AA00DABJ | MFCD04039005
478171-80-1
478171-80-1
2-METHYL-1,4-NAPHTHOQUINONE-D8
AA00DAIM | MFCD01317514
479578-95-5
479578-95-5
3-[(4-formylphenoxy)methyl]benzoic acid
AA00DAPP | MFCD02605348
52007-97-3
52007-97-3
N-(2-Phenylethyl)propan-2-amine
AA00DASI | MFCD08691704
558447-26-0
558447-26-0
(S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine
AA00DB1X | MFCD11977316
51415-02-2
51415-02-2
chikusetsu saponin IVa
AA00DB5H | MFCD22125022
450394-87-3
450394-87-3
3-(4-Oxo-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-3(4h)-yl)propanoic acid
AA00DB9G | MFCD02960611
54166-15-3
54166-15-3
Diethyl 3-(benzyloxy)cyclobutane-1,1-dicarboxylate
AA00DBFK | MFCD07700259
516-38-1
516-38-1
ALPHA-CORTOL
AA00DBM8 | MFCD00056511
507472-25-5
507472-25-5
Fmoc-(s)-3-amino-3-(2-nitro-phenyl)-propionic acid
AA00DBSX | MFCD03428007
Submit
© 2017 AA BLOCKS, INC. All rights reserved.